Download PDF
Eur J Pediatr Surg 2014; 24(04): 317-321
DOI: 10.1055/s-0033-1349058
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Sclerotherapy for Intra-abdominal Lymphatic Malformations in Children

Katie W. Russell
1   Division of Pediatric Surgery, University of Utah, Primary Children's Medical Center, Salt Lake City, Utah, United States
,
Michael D. Rollins
1   Division of Pediatric Surgery, University of Utah, Primary Children's Medical Center, Salt Lake City, Utah, United States
,
G. Peter Feola
2   Pediatric Interventional Radiology, University of Utah, Primary Children's Medical Center, Salt Lake City, Utah, United States
,
Ryan Arnold
2   Pediatric Interventional Radiology, University of Utah, Primary Children's Medical Center, Salt Lake City, Utah, United States
,
Douglas C. Barnhart
1   Division of Pediatric Surgery, University of Utah, Primary Children's Medical Center, Salt Lake City, Utah, United States
,
Eric R. Scaife
1   Division of Pediatric Surgery, University of Utah, Primary Children's Medical Center, Salt Lake City, Utah, United States
› Author Affiliations
Further Information

Publication History

17 February 2013

23 May 2013

Publication Date:
11 July 2013 (online)

    Permissions and Reprints

Abstract

Purpose Sclerotherapy is well described as a treatment for lymphatic malformations (LMs) in the head, neck, and other soft tissue areas. This study aims to evaluate the effectiveness of intralesional sclerotherapy as primary treatment for intra-abdominal LMs in children.

Methods We conducted a retrospective review from 2008 to 2012 of all children with intra-abdominal LMs treated with sclerotherapy at our tertiary children's hospital.

Results In this study, five patients underwent sclerotherapy as a primary intervention for intra-abdominal LMs. The ages of these patients ranged from 12 to 52 months at the time of initial treatment. Doxycycline was used as the primary sclerotherapy agent. The patients required between three and five (median 3) sclerosing treatments over a period that ranged from 5 to 366 days (median 28). No child has required an operation and all LMs have decreased in size. The median decease in maximum diameter is 62% (21–67). Complete resolution has not been attained but all have experienced symptomatic relief with a median follow-up of 3 (1–24) months.

Conclusions Sclerotherapy is an effective first-line therapy for intra-abdominal LMs in the pediatric population and should be considered when treating these difficult lesions.

Keywords

sclerotherapy - lymphatic malformation - doxycycline - pediatrics
 

  • References

  • 1 Hebra A, Brown MF, McGeehin KM, Ross III AJ. Mesenteric, omental, and retroperitoneal cysts in children: a clinical study of 22 cases. South Med J 1993; 86 (2) 173-176
    CrossrefPubMedGoogle Scholar
  • 2 Vanek VW, Phillips AK. Retroperitoneal, mesenteric, and omental cysts. Arch Surg 1984; 119 (7) 838-842
    CrossrefPubMedGoogle Scholar
  • 3 Steyaert H, Guitard J, Moscovici J, Juricic M, Vaysse P, Juskiewenski S. Abdominal cystic lymphangioma in children: benign lesions that can have a proliferative course. J Pediatr Surg 1996; 31 (5) 677-680
    CrossrefPubMedGoogle Scholar
  • 4 Shiels II WE, Kenney BD, Caniano DA, Besner GE. Definitive percutaneous treatment of lymphatic malformations of the trunk and extremities. J Pediatr Surg 2008; 43 (1) 136-139 , discussion 140
    CrossrefPubMedGoogle Scholar
  • 5 Ros PR, Olmsted WW, Moser Jr RP, Dachman AH, Hjermstad BH, Sobin LH. Mesenteric and omental cysts: histologic classification with imaging correlation. Radiology 1987; 164 (2) 327-332
    CrossrefPubMedGoogle Scholar
  • 6 Kosir MA, Sonnino RE, Gauderer MW. Pediatric abdominal lymphangiomas: a plea for early recognition. J Pediatr Surg 1991; 26 (11) 1309-1313
    CrossrefPubMedGoogle Scholar
  • 7 Alqahtani A, Nguyen LT, Flageole H, Shaw K, Laberge JM. 25 years' experience with lymphangiomas in children. J Pediatr Surg 1999; 34 (7) 1164-1168
    CrossrefPubMedGoogle Scholar
  • 8 Hancock BJ, St-Vil D, Luks FI, Di Lorenzo M, Blanchard H. Complications of lymphangiomas in children. J Pediatr Surg 1992; 27 (2) 220-224 , discussion 224–226
    CrossrefPubMedGoogle Scholar
  • 9 Chaudry G, Burrows PE, Padua HM, Dillon BJ, Fishman SJ, Alomari AI. Sclerotherapy of abdominal lymphatic malformations with doxycycline. J Vasc Interv Radiol 2011; 22 (10) 1431-1435
    CrossrefPubMedGoogle Scholar
  • 10 Goh BK, Tan YM, Ong HS , et al. Intra-abdominal and retroperitoneal lymphangiomas in pediatric and adult patients. World J Surg 2005; 29 (7) 837-840
    CrossrefPubMedGoogle Scholar
  • 11 Nam SH, Kim DY, Kim SC, Kim IK. The surgical experience for retroperitoneal, mesenteric and omental cyst in children. J Korean Surg Soc 2012; 83 (2) 102-106
    CrossrefPubMedGoogle Scholar
  • 12 Churchill P, Otal D, Pemberton J, Ali A, Flageole H, Walton JM. Sclerotherapy for lymphatic malformations in children: a scoping review. J Pediatr Surg 2011; 46 (5) 912-922
    CrossrefPubMedGoogle Scholar
  • 13 de Perrot M, Rostan O, Morel P, Le Coultre C. Abdominal lymphangioma in adults and children. Br J Surg 1998; 85 (3) 395-397
    CrossrefPubMedGoogle Scholar
  • 14 Ogita S, Tsuto T, Takahashi T. A case report of sclerosing therapy with OK-432 for cystic hygroma in a child. Geka 1987; 49: 421-423
    PubMedGoogle Scholar
  • 15 Ogita S, Tsuto T, Nakamura K, Deguchi E, Iwai N. OK-432 therapy in 64 patients with lymphangioma. J Pediatr Surg 1994; 29 (6) 784-785
    CrossrefPubMedGoogle Scholar
  • 16 Shergill A, John P, Amaral JG. Doxycycline sclerotherapy in children with lymphatic malformations: outcomes, complications and clinical efficacy. Pediatr Radiol 2012; 42 (9) 1080-1088
    CrossrefPubMedGoogle Scholar
  • 17 Dubois J, Garel L, Abela A, Laberge L, Yazbeck S. Lymphangiomas in children: percutaneous sclerotherapy with an alcoholic solution of zein. Radiology 1997; 204 (3) 651-654
    CrossrefPubMedGoogle Scholar
  • 18 Lee BB, Kim YW, Seo JM , et al. Current concepts in lymphatic malformation. Vasc Endovascular Surg 2005; 39 (1) 67-81
    CrossrefPubMedGoogle Scholar
  • 19 Kim KH, Sung MW, Roh JL, Han MH. Sclerotherapy for congenital lesions in the head and neck. Otolaryngol Head Neck Surg 2004; 131 (3) 307-316
    CrossrefPubMedGoogle Scholar
  • 20 Niramis R, Watanatittan S, Rattanasuwan T. Treatment of cystic hygroma by intralesional bleomycin injection: experience in 70 patients. Eur J Pediatr Surg 2010; 20 (3) 178-182
    Article in Thieme ConnectPubMedGoogle Scholar
  • 21 Boardman SJ, Cochrane LA, Roebuck D, Elliott MJ, Hartley BE. Multimodality treatment of pediatric lymphatic malformations of the head and neck using surgery and sclerotherapy. Arch Otolaryngol Head Neck Surg 2010; 136 (3) 270-276
    CrossrefPubMedGoogle Scholar
  • 22 Caliendo MV, Lee DE, Queiroz R, Waldman DL. Sclerotherapy with use of doxycycline after percutaneous drainage of postoperative lymphoceles. J Vasc Interv Radiol 2001; 12 (1) 73-77
    CrossrefPubMedGoogle Scholar
  • 23 Robinson LA, Fleming WH, Galbraith TA. Intrapleural doxycycline control of malignant pleural effusions. Ann Thorac Surg 1993; 55 (5) 1115-1121 , discussion 1121–1122
    CrossrefPubMedGoogle Scholar
  • 24 Suskind DL, Tavill MA, Handler SD. Doxycycline sclerotherapy of benign lymphoepithelial cysts of the parotid: a minimally invasive treatment. Int J Pediatr Otorhinolaryngol 2000; 52 (2) 157-161
    CrossrefPubMedGoogle Scholar
  • 25 Tang SJ, Sreenarasimhaiah J, Tang L, Rollins N, Purdy PD. Endoscopic injection sclerotherapy with doxycycline for mediastinal and esophageal lymphangiohemangioma. Gastrointest Endosc 2007; 66 (6) 1196-1200
    CrossrefPubMedGoogle Scholar
  • 26 Molitch HI, Unger EC, Witte CL, vanSonnenberg E. Percutaneous sclerotherapy of lymphangiomas. Radiology 1995; 194 (2) 343-347
    CrossrefPubMedGoogle Scholar
  • 27 Burrows PE, Mitri RK, Alomari A , et al. Percutaneous sclerotherapy of lymphatic malformations with doxycycline. Lymphat Res Biol 2008; 6 (3–4) 209-216
    CrossrefPubMedGoogle Scholar
  • 28 Nehra D, Jacobson L, Barnes P, Mallory B, Albanese CT, Sylvester KG. Doxycycline sclerotherapy as primary treatment of head and neck lymphatic malformations in children. J Pediatr Surg 2008; 43 (3) 451-460
    CrossrefPubMedGoogle Scholar
  • 29 Hurewitz AN, Lidonicci K, Wu CL, Reim D, Zucker S. Histologic changes of doxycycline pleurodesis in rabbits. Effect of concentration and pH. Chest 1994; 106 (4) 1241-1245
    CrossrefPubMedGoogle Scholar
  • 30 Gilony D, Schwartz M, Shpitzer T, Feinmesser R, Kornreich L, Raveh E. Treatment of lymphatic malformations: a more conservative approach. J Pediatr Surg 2012; 47 (10) 1837-1842
    CrossrefPubMedGoogle Scholar
  • 31 Mabrut JY, Grandjean JP, Henry L , et al. [Mesenteric and mesocolic cystic lymphangiomas. Diagnostic and therapeutic management]. Ann Chir 2002; 127 (5) 343-349
    CrossrefPubMedGoogle Scholar